Home Healthcare IT Minimally Invasive Surgeries Market Size, Growth & Demand By 2033

Minimally Invasive Surgeries Market Size, Share & Trends Analysis Report By Procedure (Laparoscopic Surgery, Robotic Surgery, Endoscopic Mucosal Resection, Endoscopic Sub-mucosal Dissection), By Application (Cardiac Surgery, Gastrointestinal Surgery, Orthopedics and Spine Surgery, Gynecological Surgery, Thoracic Surgery, Cosmetic Surgery, Others), By End-User (Hospital, Surgical Clinics, Ambulatory Surgical Centers (ASCs)) and By Region(North America, Europe, APAC, Middle East and Africa, LATAM) Forecasts, 2025-2033

Report Code: SRHI593DR
Author : Straits Research
Study Period 2021-2033 CAGR 7.8%
Historical Period 2021-2023 Forecast Period 2025-2033
Base Year 2024 Base Year Market Size USD 78.45 billion
Forecast Year 2033 Forecast Year Market Size USD 241.93 billion
Largest Market Asia Pacific Fastest Growing Market North America

Minimally Invasive Surgeries Market Size

The global minimally invasive surgeries market size was valued at USD 78.45 billion in 2024 and is estimated to grow from USD 88.91 billion in 2025 to reach USD 241.93 billion by 2033, growing at a CAGR of 13.33% during the forecast period (2025–2033). 

A key driver of the global minimally invasive surgeries (MIS) market is the growing geriatric population, which is more susceptible to chronic illnesses such as cancer, cardiovascular conditions, and orthopedic disorders. MIS techniques offer advantages like shorter recovery time, reduced hospital stays, and minimal scarring, making them ideal for elderly patients. Additionally, the rapid expansion of outpatient and ambulatory surgical centers (ASCs) has increased access to these procedures, particularly due to their cost-efficiency and convenience.

Furthermore, technological advancements in surgical navigation, imaging systems, and energy-based devices have further enhanced the accuracy and safety of MIS. High-definition 3D imaging and advanced laparoscopic tools allow surgeons to perform difficult procedures with better outcomes. Moreover, favorable reimbursement policies and government support in regions like North America and Europe are encouraging healthcare providers to adopt minimally invasive techniques over traditional open surgeries.


Latest Market Trends 

Rising adoption of robotic-assisted surgeries

The rising adoption of robotic-assisted surgeries is revolutionizing the minimally invasive surgeries (MIS) market by offering enhanced precision, reduced trauma, and faster patient recovery. Robotic systems allow surgeons to operate with greater dexterity and visual clarity, particularly in complex procedures.

  • A notable example is Intuitive Surgical’s da Vinci systems, which continue to dominate this segment. As per Intuitive Surgical’s 2024 report, approximately 2.7 million procedures were conducted using da Vinci systems a 17% rise from 2023. The total global usage now nears 17 million procedures. In 2024, 1,430 da Vinci multiport, 271 Ion, and 96 SP systems were installed, reflecting rising robotic surgery adoption. 

These trends indicate a strong market inclination toward technologically advanced, efficient, and less invasive surgical methods. 

Minimally Invasive Surgeries Market Drivers

Rising prevalence of lifestyle-related disorders

The rising prevalence of lifestyle-related disorders is a significant driver of growth in the global minimally invasive surgeries (MIS) market. Conditions such as obesity, type 2 diabetes, cardiovascular disease, and gallstones are increasingly common due to sedentary habits, unhealthy diets, and stress. These disorders often require surgical interventions, and MIS provides a less invasive, safer, and quicker alternative to traditional open surgeries.

  • According to the World Obesity Federation 2024 report, over 1 billion people globally are expected to be obese by 2030. Additionally, according to the WHO, the global diabetic population surged from 200 million in 1990 to 830 million in 2022 and is anticipated to reach 853 million by 2050.

These trends are driving demand for procedures like laparoscopic bariatric surgery and minimally invasive cardiac interventions, positioning MIS as a crucial solution to modern health challenges. 

Market Restraint 

High cost of advanced MIS equipment and robotic systems

One of the major restraints in the global minimally invasive surgeries (MIS) market is the high cost of advanced surgical equipment and robotic systems. Technologies such as robotic-assisted surgery platforms, high-definition imaging, and precision instruments involve significant capital investment, often ranging from hundreds of thousands to millions of dollars.

This cost burden is specifically challenging for small- and medium-sized hospitals and healthcare centers in low- and middle-income countries, limiting widespread adoption. Additionally, ongoing maintenance, consumables, and training expenses further increase the total cost of ownership. As a result, access to cutting-edge MIS technology remains limited in several regions, slowing overall market penetration and growth. 

Market Opportunities

Innovation in single-incision and natural orifice transluminal endoscopic surgeries (NOTES) 

One of the most promising opportunities in the global minimally invasive surgeries (MIS) market lies in the advancement of single-incision and natural orifice transluminal endoscopic surgeries (NOTES). These techniques aim to minimize external incisions, improve cosmetic outcomes, and reduce recovery time. Innovations such as robotic assistance are significantly enhancing the feasibility and precision of these procedures.

  • For instance, an MDPI study published in March 2025 evaluated robot-assisted vNOTES in complex gynecologic procedures (e.g., endometriosis excision). Results show RA vNOTES is feasible and less invasive, with around 17.5% complication rate (2.1% intraoperative, 15.4% postoperative), suggesting promising but careful application.

As demand rises for ultra-minimally invasive interventions, companies investing in next-gen NOTES-compatible robotic platforms are likely to benefit from increased clinical adoption and commercial growth in emerging and developed markets alike.

Talk to us
If you have a specific query, feel free to ask our experts.

Regional Insights

The North American market for minimally invasive surgeries is experiencing consistent growth, driven by advanced healthcare infrastructure, high adoption of robotic and image-guided surgeries, and growing awareness of patient benefits such as reduced scarring and quicker recovery. The region also benefits from strong R&D funding and early adoption of AI-integrated surgical platforms. Expanding outpatient surgery centers and favorable reimbursement structures further support growth. The surging prevalence of chronic diseases and obesity continues to elevate procedural demand, making MIS an essential component of the regional surgical landscape. 

  • Canada’s minimally invasive surgeries market is expanding due to the increasing adoption of laparoscopic procedures across public hospitals. Institutions like Toronto General Hospital are integrating robotic-assisted platforms. Government funding through provincial healthcare plans and initiatives like the Canadian Partnership Against Cancer promotes MIS for faster recovery. Additionally, the country’s growing elderly population and focus on reducing hospital stays are boosting demand for minimally invasive solutions. 

U.S. Minimally Invasive Surgeries Market Trends

  • The United States market is driven by advanced surgical technologies and a high volume of elective procedures. Institutions like the Mayo Clinic and the Cleveland Clinic are pioneering robotic and laparoscopic techniques. The U.S. FDA’s regular approvals for innovative devices, such as Intuitive Surgical’s da Vinci system, fuel adoption. Strong reimbursement policies and high healthcare spending further support the market’s growth. 

Asia-Pacific Market Trends

Asia Pacific is witnessing robust growth in the MIS market, fueled by rising healthcare investments, medical tourism, and increasing patient awareness of minimally invasive options. Rapid urbanization and lifestyle changes are leading to higher incidences of chronic diseases, boosting surgical procedure volumes. Improved access to healthcare, expanding private hospital chains, and increasing availability of skilled surgeons are accelerating MIS uptake. Local manufacturing of surgical instruments and government support for medical technology innovation further enhance regional capabilities, positioning Asia Pacific as a fast-growing hub for minimally invasive procedures. 

  • Japan's market is driven by its aging population and advanced healthcare infrastructure. The high adoption of robotic-assisted systems, such as the da Vinci Surgical System, improves precision in complex procedures. Japanese hospitals increasingly prefer MIS for gastrointestinal and urological surgeries. Government-backed initiatives for cost containment and surgical innovation also support minimally invasive surgeries market growth. For example, Tokyo Medical University Hospital is actively expanding its laparoscopic surgery programs. 
  • India's minimally invasive surgeries industry is expanding rapidly due to rising medical tourism, growing middle-class income, and improved hospital infrastructure. Increasing adoption of laparoscopic procedures in tier-1 cities and affordable robotic solutions like SS Innovations’ Mantra system are transforming access. MIS is becoming preferred for gynecological and bariatric surgeries. Institutions like AIIMS and Apollo Hospitals are promoting surgeon training in MIS techniques, accelerating nationwide adoption. 

Europe Market Trends

Europe’s MIS market is expanding steadily due to an aging population, rising healthcare expenditures, and growing preference for non-invasive treatment alternatives. Technological innovations, such as high-definition endoscopy and robotic-assisted surgeries, are being rapidly integrated across public and private healthcare systems. Emphasis on reducing hospital stay durations and surgical complications aligns well with the shift toward minimally invasive methods. Strong clinical research presence and medical device innovation also contribute to regional growth, with surgical training programs advancing to support widespread MIS adoption across diverse medical specialties. 

  • Germany’s market is driven by a robust healthcare infrastructure and advanced surgical training programs. The adoption of robotic-assisted procedures is increasing in hospitals like Charité – Universitätsmedizin Berlin. Government support for technology integration and a focus on reducing hospital stays also fuel demand. Additionally, Germany’s aging population is contributing to higher MIS usage in orthopedic and cardiovascular surgeries, promoting the long-term market growth. 
  • The UK’s market for minimally invasive surgeries benefits from the National Health Service’s (NHS) initiatives to reduce surgery waiting times and hospital stays. Facilities such as Guy’s and St Thomas’ Hospital in London are increasingly implementing laparoscopic and robotic-assisted surgeries. Moreover, the rising preference for day surgeries and a strong focus on cost-effective care are pushing MIS adoption across the country, especially for gastrointestinal and gynecological procedures.
Need a Custom Report?

We can customize every report - free of charge - including purchasing stand-alone sections or country-level reports


Device Type Insights

Surgical instruments hold the largest share in the minimally invasive surgeries market due to their fundamental role in every procedure. Devices like forceps, scissors, trocars, sutures, and retractors are essential across various surgical specialties. Their consistent demand, reusability, and ongoing enhancements in ergonomics and precision drive segment growth. Additionally, the growing volume of MIS procedures globally fuels the need for high-performance instruments, making this segment a cornerstone of surgical interventions across hospitals and ambulatory centers. 

Procedure Insights

Laparoscopic surgery is a significant procedure segment owing to its widespread application in gastrointestinal, gynecological, and urological surgeries. The technique's benefits, including reduced postoperative pain, faster recovery, and minimal scarring, have made it a preferred choice among surgeons and patients. With advancements in laparoscopic tools and imaging technologies, such as HD and 3D visualization, the efficacy and safety of these procedures continue to improve. Increasing global awareness and access to minimally invasive options further support the segment’s expansion. 

Application Insights

Cardiac surgery stands as a leading application in the minimally invasive surgeries industry, driven by the rising prevalence of cardiovascular diseases and a global shift toward less invasive interventions. Procedures like minimally invasive coronary artery bypass and valve repair/replacement are gaining traction due to reduced recovery time and fewer complications. Technological advancements in surgical robotics and imaging further enhance precision in cardiac procedures. The aging population and demand for cost-effective, safer alternatives to open-heart surgery bolster this segment's dominance. 

End-user Insights

Hospitals dominate the end-user segment due to their advanced infrastructure, availability of skilled surgeons, and adoption of cutting-edge surgical technologies. They are primary centers for complex minimally invasive procedures, often equipped with robotic systems, high-definition imaging devices, and comprehensive postoperative care. Hospitals also benefit from better funding and streamlined procurement systems, enabling quicker adoption of new MIS tools. Their capability to handle an extensive range of surgical specialties positions them as the key contributors to market demand. 

Market Size By Procedure

Market Size By Procedure
Laparoscopic Surgery Robotic Surgery Endoscopic Mucosal Resection Endoscopic Sub-mucosal Dissection Needle-Based Surgery Arthroscopic Surgery Percutaneous Surgery Others

Company Market Share  

Companies in the minimally invasive surgeries market are focusing on extending their product portfolios through continuous innovation in robotic-assisted systems, advanced imaging technologies, and AI-integrated tools. They are also investing in strategic partnerships with hospitals and research institutions, enhancing surgeon training programs and expanding their presence in emerging markets. Additionally, efforts are being made to improve patient outcomes and reduce procedural costs, driving increased adoption of minimally invasive techniques globally. 

Intuitive Surgical Inc. : Intuitive Surgical Inc. is a leading U.S.-based company renowned for pioneering robotic-assisted minimally invasive surgery. Founded in 1995 and headquartered in Sunnyvale, California, it is best known for its da Vinci Surgical System, which revolutionized surgery across urology, gynecology, and general procedures. With a strong global footprint, continuous innovation, and significant R&D investment, Intuitive Surgical holds a dominant share in the robotic surgery segment, shaping the future of precision surgery through advanced robotics, AI integration, and surgeon training programs. 

  • In April 2025, Intuitive’s da Vinci Single-Port (SP) System received expanded FDA clearance for use in multiple surgical disciplines, including urology, colorectal, and thoracic procedures. This system enables surgeons to perform complex minimally invasive surgeries through a single small incision, enhancing precision and patient recovery outcomes, and further strengthening Intuitive’s leadership in robotic-assisted surgery. 

List of key players in Minimally Invasive Surgeries Market

  1. Medtronic plc 
  2. Johnson & Johnson (Ethicon Inc.) 
  3. Stryker Corporation 
  4. Olympus Corporation 
  5. Intuitive Surgical Inc. 
  6. Zimmer Biomet Holdings Inc. 
  7. Smith & Nephew plc 
  8. B. Braun Melsungen AG 
  9. Boston Scientific Corporation 
  10. CONMED Corporation 
Minimally Invasive Surgeries Market Share of Key Players

Recent Developments 

  • June 2025- IMRA, the Melbourne-based medtech startup valued at around $25 million, has secured major partnerships with Medtronic, Johnson & Johnson, Olympus, and Intuitive Surgical to develop hyper‑realistic synthetic surgical models. Powered by AI in collaboration with CSIRO and RMIT, these cost‑effective, customizable hydrogel models offer realistic, animal‑free training and objective surgeon assessment, perfectly timed as the FDA phases out animal testing. 
  • May 2025- Medtronic obtained European CE‑Mark approval for its Evolut Pro+ and FX transcatheter aortic valve replacement (TAVR) systems under an expanded “redo TAVR” indication. This approval enables implantation of a new Evolut valve inside any previously failed TAV regardless of the original manufacturer offering a minimally invasive option for high‑risk patients and enhancing lifetime management of aortic stenosis. 
  • January 2025- AdventHealth Redmond launched Northwest Georgia’s first minimally invasive stroke surgery program, led by Dr. Jose Marino. Using live X-ray guided thrombectomy, the interventional neurology team can swiftly remove clots and treat aneurysms onsite eliminating the need for patient transfers. The initiative aims to reduce treatment times under 30 minutes, improve outcomes, and save more lives locally. 

Minimally Invasive Surgeries Market Segmentations

By Procedure (2021-2033)

  • Laparoscopic Surgery
  • Robotic Surgery
  • Endoscopic Mucosal Resection
  • Endoscopic Sub-mucosal Dissection
  • Needle-Based Surgery
  • Arthroscopic Surgery
  • Percutaneous Surgery
  • Others

By Device Type (2021-2033)

  • Surgical Instruments
  • Forceps, Scissors
  • Trocars
  • Dilators and Retractors
  • Sutures and Staplers
  • Endoscopic Devices
  • Rigid and Flexible Endoscopes
  • Monitoring and Visualization Systems
  • Laparoscopes
  • Cameras
  • Light Sources
  • Robotic Surgical Systems
  • Insufflators
  • Electrosurgical Devices
  • Handheld Instruments
  • Ablation and Energy Devices

By Application (2021-2033)

  • Cardiac Surgery
  • Gastrointestinal Surgery
  • Orthopedics and Spine Surgery
  • Gynecological Surgery
  • Thoracic Surgery
  • Cosmetic Surgery
  • Others

By End-User (2021-2033)

  • Hospital
  • Surgical Clinics
  • Ambulatory Surgical Centers (ASCs)
  • Others

By Region (2021-2033)

  • North America
  • Europe
  • APAC
  • Middle East and Africa
  • LATAM

Frequently Asked Questions (FAQs)

How Big is Minimally Invasive Surgeries Market?
The global minimally invasive surgeries market size was valued at USD 78.45 billion in 2024 and is estimated to grow from USD 88.91 billion in 2025 to reach USD 241.93 billion by 2033, growing at a CAGR of 13.33% during the forecast period (2025–2033).
Some of the top prominent players in Minimally Invasive Surgeries Market are, University of Pittsburgh Medical Center, Rutland Medical Center, Huntington Hospital, Washington Hospital Healthcare System, The Ottawa Hospital, Michael's Hospital, Charité - Universitätsmedizin Berlin, Ipswich Hospital, Apollo Hospitals Enterprise Limited, HealthCare Global Enterprises Ltd., etc.
In the global market, Asia- Pacific has established itself as the market leader with a significant market share.
The region with the most rapid expansion in the global market is North America.
Laparoscopic surgery leads the procedure type segment owing to its widespread application in gastrointestinal
Straits Research - Access Portal
  • 📊 Preview Report Scope and Structure – Gain immediate visibility into key topics, market segments, and data frameworks covered.
  • 📥 Evaluate Strategic Insights – Access selected charts, statistics, and analyst-driven commentary derived from the final report deliverables.



We are featured on :